Derek L Weyhrauch1, Dongngan T Truong2, Nelangi M Pinto2, Venugopal Amula2, Linda M Lambert2, Chong Zhang3, Angela P Presson3, Jacob Wilkes4, L LuAnn Minich2, Richard V Williams2. 1. University of Utah Division of Pediatric Cardiology and Primary Children's Hospital, 81 N. Mario Capecchi Drive, Salt Lake City, UT, 84113, USA. derek.weyhrauch@gmail.com. 2. University of Utah Division of Pediatric Cardiology and Primary Children's Hospital, 81 N. Mario Capecchi Drive, Salt Lake City, UT, 84113, USA. 3. Division of Epidemiology, University of Utah, Salt Lake City, UT, USA. 4. Pediatric Analytics, Intermountain Healthcare, Salt Lake City, UT, USA.
Abstract
BACKGROUND: The impact of published evidence on clinical practice has been understudied in pediatric cardiology. OBJECTIVE: We sought to assess changes in prescribing behavior for angiotensin-converting enzyme inhibitor (ACEI) and digoxin at discharge after initial palliation of infants with single ventricle (SV) physiology following the publication of two large studies: The Pediatric Heart Network Infant Single Ventricle (PHN-ISV) trial showing no benefit with routine ACEI use and the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) analysis showing an association between digoxin and survival. METHODS: ICD-9-10 codes identified SV infants from the Pediatric Health Information System (1/2004 to 1/2018) and charge codes identified medications at discharge. Generalized estimating equations implementing segmented logistic regressions modeled medication use, before and after (with a 3-month washout period) the relevant publication (ACEI 7/1/2010; digoxin 4/1/2016). A subgroup analysis was performed for hypoplastic left heart syndrome (HLHS). RESULTS: ACEI use (37 centers, n = 4700) at discharge did not change over time during the pre-publication period. After publication of the PHN-ISV trial, ACEI use decreased (OR: 0.61, CI 0.44-0.84, p = 0.003). Digoxin use (43 centers, n = 4778) decreased by 1% monthly before publication. After the NPC-QIC publication, digoxin use increased (OR: 2.07, CI 1.05-4.08, p = 0.04) with an ongoing increase of 9% per month. Results were similar for the HLHS subgroup. CONCLUSIONS: Prescribing behavior changed congruently after the publication of evidence-based studies, with decreased ACEI use and increased digoxin use at discharge following initial palliation of SV infants. Our findings suggest scientific findings were rapidly implemented into clinical practice.
BACKGROUND: The impact of published evidence on clinical practice has been understudied in pediatric cardiology. OBJECTIVE: We sought to assess changes in prescribing behavior for angiotensin-converting enzyme inhibitor (ACEI) and digoxin at discharge after initial palliation of infants with single ventricle (SV) physiology following the publication of two large studies: The Pediatric Heart Network Infant Single Ventricle (PHN-ISV) trial showing no benefit with routine ACEI use and the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) analysis showing an association between digoxin and survival. METHODS: ICD-9-10 codes identified SV infants from the Pediatric Health Information System (1/2004 to 1/2018) and charge codes identified medications at discharge. Generalized estimating equations implementing segmented logistic regressions modeled medication use, before and after (with a 3-month washout period) the relevant publication (ACEI 7/1/2010; digoxin 4/1/2016). A subgroup analysis was performed for hypoplastic left heart syndrome (HLHS). RESULTS: ACEI use (37 centers, n = 4700) at discharge did not change over time during the pre-publication period. After publication of the PHN-ISV trial, ACEI use decreased (OR: 0.61, CI 0.44-0.84, p = 0.003). Digoxin use (43 centers, n = 4778) decreased by 1% monthly before publication. After the NPC-QIC publication, digoxin use increased (OR: 2.07, CI 1.05-4.08, p = 0.04) with an ongoing increase of 9% per month. Results were similar for the HLHS subgroup. CONCLUSIONS: Prescribing behavior changed congruently after the publication of evidence-based studies, with decreased ACEI use and increased digoxin use at discharge following initial palliation of SV infants. Our findings suggest scientific findings were rapidly implemented into clinical practice.
Entities:
Keywords:
Evidence-based medicine; Provider behavior; Single ventricle
Authors: Victor Zak; Daphne T Hsu; Victoria L Pemberton; Jami C Levine; Andrew M Atz; James F Cnota; Chitra Ravishankar; Piers Barker; Linda M Lambert; Brian W McCrindle; Michele A Frommelt; Karen Altmann; Shan Chen; Richard V Williams Journal: Cardiol Young Date: 2017-02-10 Impact factor: 1.093
Authors: Daphne T Hsu; Victor Zak; Lynn Mahony; Lynn A Sleeper; Andrew M Atz; Jami C Levine; Piers C Barker; Chitra Ravishankar; Brian W McCrindle; Richard V Williams; Karen Altmann; Nancy S Ghanayem; Renee Margossian; Wendy K Chung; William L Border; Gail D Pearson; Mario P Stylianou; Seema Mital Journal: Circulation Date: 2010-07-12 Impact factor: 29.690
Authors: David W Brown; Colleen Mangeot; Jeffrey B Anderson; Laura E Peterson; Eileen C King; Stacey L Lihn; Steven R Neish; Craig Fleishman; Christina Phelps; Samuel Hanke; Robert H Beekman; Carole M Lannon Journal: J Am Heart Assoc Date: 2016-01-11 Impact factor: 5.501
Authors: Matthew E Oster; Michael Kelleman; Courtney McCracken; Richard G Ohye; William T Mahle Journal: J Am Heart Assoc Date: 2016-01-13 Impact factor: 5.501
Authors: Dwight M Robertson; Dongngan T Truong; Daniel A Cox; Harris L Carmichael; Zhining Ou; L LuAnn Minich; Richard V Williams; E Seda Selamet Tierney Journal: Pediatr Cardiol Date: 2022-07-28 Impact factor: 1.838